论文部分内容阅读
恶性肿瘤的化学治疗导致白细胞减少症常成为化疗顺利进行的一大障碍。为此，我科自1997年8月～1998年9月对收治的各种恶性肿瘤患者化疗后进行升白欣治疗观察39例，经严格设计，统计学处理。结果表明：升白欣具有明显的升白作用，且起效快，维持时间较长。
Chemotherapy of malignant tumors leads to leucopenia and often becomes a major obstacle to the smooth progress of chemotherapy. Therefore, in our department, from August 1997 to September 1998, 39 cases of patients with malignant tumors treated with chemotherapy were treated with Shengbaixin, and they were strictly designed and analyzed statistically. The results show that Shengbaixin has obvious effect of promoting whitening, and it has quick effect and long maintenance time.